E
PFE icon

Ergoteles’s Pfizer PFE Stock Holding History

Ergoteles’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28,606
Closed -$1.47M – 1644
2022
Q4 		$1.47M Buy
28,606
+4,063
+17% +$195K 0.05% 355
2022
Q3 		$1.07M Sell
24,543
-33,821
-58% -$1.64M 0.04% 454
2022
Q2 		$3.06M Buy
58,364
+21,598
+59% +$1.1M 0.09% 224
2022
Q1 		$1.9M Buy
36,766
+21,209
+136% +$1.1M 0.07% 266
2021
Q4 		$919K Buy
+15,557
New +$771K 0.04% 436

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ergoteles's PFE Position: Q1 2023 in Review

Ergoteles sold out of Pfizer (PFE) in Q1 2023, closing a stake of 28,606 shares — an estimated $1.47M sold.

Ergoteles first reported a position in PFE in Q4 2021 and held it in 5 quarters. The position peaked at $3.06M in Q2 2022. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Ergoteles reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 28,606 Pfizer shares in Q1 2023, an estimated $1.47M.
  • Ergoteles first reported a position in Pfizer in Q4 2021 and held it in 5 quarters.
  • Ergoteles's Pfizer position peaked at $3.06M in Q2 2022.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.